Authors:
Crawford, ED
Leewansangtong, S
Goktas, S
Holthaus, K
Baier, M
Citation: Ed. Crawford et al., Efficiency of prostate-specific antigen and digital rectal examination in screening, using 4.0 ng/ml and age-specific reference range as a cutoff forabnormal values, PROSTATE, 38(4), 1999, pp. 296-302
Citation: M. Koutsilieris et al., Novel concept of antisurvival factor (ASF) therapy produces an objective clinical response in four patients with hormone-refractory prostate cancer: Case report, PROSTATE, 38(4), 1999, pp. 313-316
Citation: Abstracts from the 1998 International Symposium on Biology of Prostate Growth - National Institutes of Health - Natcher Conference Center - Bethesda,Maryland - March 15-18, 1998, PROSTATE, 38(4), 1999, pp. 317-360
Citation: S. Aaltomaa et al., Expression of cyclin A and D proteins in prostate cancer and their relation to clinopathological variables and patient survival, PROSTATE, 38(3), 1999, pp. 175-182
Authors:
Stege, RH
Tribukait, B
Carlstrom, KAM
Grande, M
Pousette, AHL
Citation: Rh. Stege et al., Tissue PSA from fine-needle biopsies of prostatic carcinoma as related to serum PSA, clinical stage, cytological grade, and DNA ploidy, PROSTATE, 38(3), 1999, pp. 183-188
Authors:
Eichholzer, M
Stahelin, HB
Ludin, E
Bernasconi, F
Citation: M. Eichholzer et al., Smoking, plasma vitamins C, E, retinol, and carotene, and fatal prostate cancer: Seventeen-year follow-up of the prospective Basel study, PROSTATE, 38(3), 1999, pp. 189-198
Authors:
Goepel, M
Hecker, U
Krege, S
Rubben, H
Michel, MC
Citation: M. Goepel et al., Saw palmetto extracts potently and noncompetitively inhibit human alpha(1)-adrenoceptors in vitro, PROSTATE, 38(3), 1999, pp. 208-215
Citation: P. Smith et al., Influence of the alpha(1)-adrenergic antagonist, doxazosin, on noradrenaline-induced modulation of cytoskeletal proteins in cultured hyperplastic prostatic stromal cells, PROSTATE, 38(3), 1999, pp. 216-227
Authors:
Liang, JY
Fontana, JA
Rao, JN
Ordonez, JV
Dawson, MI
Shroot, B
Wilber, JF
Feng, P
Citation: Jy. Liang et al., Synthetic retinoid CD437 induces S-phase arrest and apoptosis in human prostate cancer cells LNCaP and PC-3, PROSTATE, 38(3), 1999, pp. 228-236
Citation: Abstracts from the 1998 International Symposium on Biology of Prostate Growth - National Institutes of Health - Natcher Conference Center - Bethesda,Maryland - March 15-18, 1998, PROSTATE, 38(3), 1999, pp. 247-258
Authors:
Labrie, F
Candas, B
Dupont, A
Cusan, L
Gomez, JL
Suburu, RE
Diamond, P
Levesque, J
Belanger, A
Citation: F. Labrie et al., Screening decreases prostate cancer death: First analysis of the 1988 Quebec prospective randomized controlled trial, PROSTATE, 38(2), 1999, pp. 83-91
Authors:
Rosendahl, I
Kiebert, GM
Curran, D
Cole, BF
Weeks, JC
Denis, LJ
Hall, RR
Citation: I. Rosendahl et al., Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: Comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer, PROSTATE, 38(2), 1999, pp. 100-109
Authors:
Sensibar, JA
Pruden, ST
Kasjanski, RZ
Rademaker, A
Lee, C
Grayhack, JT
Kozlowski, JM
Citation: Ja. Sensibar et al., Differential growth rates in stromal cultures of human prostate derived from patients of varying ages, PROSTATE, 38(2), 1999, pp. 110-117
Authors:
Garde, SV
Basrur, VS
Li, L
Finkelman, MA
Krishan, A
Wellham, L
Ben-Josef, E
Haddad, M
Taylor, JD
Porter, AT
Tang, DG
Citation: Sv. Garde et al., Prostate secretory protein (PSP94) suppresses the growth of androgen-independent prostate cancer cell line (PC3) and xenografts by inducing apoptosis, PROSTATE, 38(2), 1999, pp. 118-125
Authors:
Turk, TMT
Rees, MA
Pietrow, P
Myers, CE
Mills, SE
Gillenwater, JY
Citation: Tmt. Turk et al., Determination of optimal freezing parameters of human prostate cancer in anude mouse model, PROSTATE, 38(2), 1999, pp. 137-143
Citation: Rg. Nixon et al., Differences in prostate size between patients from university and veteransaffairs medical center populations, PROSTATE, 38(2), 1999, pp. 144-150
Authors:
Koppan, M
Nagy, A
Schally, AV
Plonowski, A
Halmos, G
Arencibia, JM
Groot, K
Citation: M. Koppan et al., Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits the growth of PC-82 human prostate cancer in nude mice, PROSTATE, 38(2), 1999, pp. 151-158
Citation: Dj. Tindall et Pt. Scardino, Defeating prostate cancer: Crucial directions for research-excerpt from the report of the prostate cancer progress review group, PROSTATE, 38(2), 1999, pp. 166-171